Ferriol-González, Celia
Hernanz-Grimalt, Ana
Valdivia, Carlos
García-Cobos, Silvia
Heredia, Ana
García-Hernández, Jorge
Andrés, Ana
Domingo-Calap, Pilar
Funding for this research was provided by:
Universitat de València (UV-INV_PREDOC-1913324)
Ministerio de Ciencia, Innovación y Universidades (PREP2023-001677)
Ministerio de Ciencia, Innovación y Universidades (PID2023-150309OB-I00)
Generalitat Valenciana (CIACIF/2023/126)
Article History
Received: 21 August 2025
Accepted: 17 December 2025
First Online: 8 January 2026
Declarations
:
: This study was conducted in accordance with the principles of the Declaration of Helsinki. The protocol was approved by the Ethical Committee for Research of Universitat Politécnica de València (P13_23-10–2024). The three donors were rigorously informed about the aims and procedures of this study and consented to participate.
: Not applicable.
: P.D.-C. is co-founder of Evolving Therapeutics SL and a member of its scientific advisory board.